Peptide Purity & Testing Standards

Peptide Purity and Testing: HPLC, MS and COA Basics

Peptide quality cannot be reduced to a single percentage. Identity, chromatographic purity, content, related impurities, water content and physical stability are different attributes, and each analytical method answers a different question.

Scientific illustration comparing chromatographic purity and mass-spectrometry identity testing.
Purity and identity are complementary analytical questions: chromatography separates detected components, while mass spectrometry supports molecular-identity assessment.

Identity, purity and content are not synonyms

  • Identity asks whether the material matches the expected compound or sequence.
  • Chromatographic purity describes the relative distribution of detected peaks under a stated method.
  • Content concerns how much target material is present in a defined quantity.
  • Impurity profile considers related species, degradation products and other detected components.

A high main-peak percentage does not, by itself, prove molecular identity or establish exact vial content.

What HPLC contributes

High-performance liquid chromatography separates components according to their interaction with a stationary phase and mobile phase. Reversed-phase HPLC is widely used for peptide characterisation. Results depend on the method, detector, integration rules, reference materials and sample preparation, so a number should be read with its analytical context.

What mass spectrometry contributes

Mass spectrometry provides molecular-mass information and can support identity assessment. LC-MS combines chromatographic separation with mass detection. More detailed sequence or impurity work may use tandem or high-resolution techniques. Orthogonal methods are valuable because no single test captures every quality attribute.

How to read a Certificate of Analysis

A useful COA should identify the product, batch or lot, test method, result, specification where applicable, test date and responsible laboratory or reviewer. Check whether the document refers to the exact batch on the listing and whether the stated method supports the claim being made.

NutriMax analysis information

Visit Lab Analysis for available NutriMax documentation. Researchers should review the original report and their own method requirements rather than relying solely on a marketing summary.

Worked example: reading a published peptide COA

Open the MZ Biolabs BPC-157 report signed 12 November 2024 (PDF) alongside these notes. This is a historical report for the sample identified in the document, not a certificate for every BPC-157 product or current batch.

  1. Identify the sample and client. Page 1 names BPC-157 (Bepecin), describes a 5 mg sample and identifies Peak Body Nutrition as the client. The stated lot is 2024-10-30. Match that identifier to supporting supply records before applying the report to stock.
  2. Separate the dates. The analysis date is 7 November 2024; the signature is dated 12 November 2024. Neither date is a shelf-life or expiry statement.
  3. Read the purity result with its method. The method is HPLC-UV-MS. Page 1 reports 98.75% for the BPC-157 peak at 6.94 minutes and 1.25% for another detected peak. These are chromatographic peak-area results under the stated analysis, not a measurement that every vial contains exactly its labelled amount.
  4. Check the separate identity evidence. Page 2 reports an expected monoisotopic mass of 1418.70 Da and a measured value of 1418.71 Da, with identity confirmed by the laboratory using HPLC-MS. This answers a different question from the UV purity percentage.
  5. Notice what is not established. The report does not present sterility, endotoxin, long-term stability or human-safety results. It also notes that some salts and sugars are not normally detected by UV. A high peak-area percentage must not be used as a substitute for those separate assessments.

Does a historical report cover current stock?

A matching compound name alone is insufficient. The sample or lot identifier, product presentation and supply records must connect the report to the material being assessed. Where that connection is not provided, treat the document as historical evidence and ask for batch-specific documentation. A report for one presentation should not automatically be extended to another size or formulation.

Questions to ask about a COA

  • Which exact sample or lot was tested, and how does it relate to the listing?
  • Which method supports identity, which supports purity, and is content separately measured?
  • Are results, units, dates and the responsible laboratory clearly stated?
  • Which relevant attributes were not tested or not reported?

For product-label terminology, see How to Read a Research Product Listing. For published documents, visit Lab Analysis.

Selected references

Supplied for research purposes only. NutriMax PES products are not intended for human or veterinary use, consumption, diagnosis or treatment. This guide explains documentation, not administration or preparation procedures. See the Global Legality Guide for regulatory context.